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Summary
Hyperthermia is a rapidly developing treatment method in oncol-
ogy.
The classical effect is based on well-focused energy absorption
targeting the malignant tissue.
Unfortunately, the heat-shock protein (HSP) synthesis may con-
siderably suppress the treatment’s efficiency, causing cells to adapt
and survive the shock. Electro-hyperthermia heats the targeted tissue
by means of electricity, producing less HSP in the cells than classi-
cal hyperthermia.
The main improvement is keeping the energy absorption within
the extracellular matrix (ECM). By heating the ECM, ion-mobility
increases, metabolic rates increase, and the heat destroys the cells’
membrane before the heat-shock activates the intra-cellular HSP
mechanisms.
1. Introduction
There are intensive discussions in scientific communities on the
mechanism of oncological hyperthermia. The number of conferences
and journals on the subject has escalated.
The increasing number of applications and clinical trials at uni-
versities, clinics, hospitals and institutes prove the feasibility and
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2. Effects of Hyperthermia
Some well-established milestones can help summarize the effects
of hyperthermia:
1. At the increase of the temperature, the blood supply of tumors
decreases while that of healthy tissue increases. [13 ].
2. As the metabolism of tumors is very intensive, it is usually warmer
than healthy tissues. [14 ].
3. There is not enough oxygen available for the metabolism of malignant
tissues; resulting in hypoxia and anaerobe metabolism, which in
turn produces acidosis. [15 ].
4. Increased metabolism significantly depletes the ATP stores of the
cells, resulting in increased apoptosis. [15].
5. DNA replication can often be blocked by heat, therefore slowing
down cell division. [16 ].
6. Hyperthermia complements ionizing radiation:
applicability of clinical hyperthermia in cancer therapies. Some of
these are summarised below.
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7. The chemo-therapies also can be complemented by hyperthermia
8. Hyperthermia has significant pain-reduction and few side effects.
[17 ].
9. Hyperthermia enhances the efficiency of the immune system [16].
3. Heat Shock Protein Production
HSPs (stress- or heat-shock-proteins) are highly conserved pro-
teins, which are vital in almost every living cell [18 ]. Stresses acti-
vate their synthesis [19 ], and HSPs help cells accommodate to new
challenges. HSPs are present in all cancerous cells helping them to
adapt to stresses and help tumor-cells survival. Moreover HSPs are
induced by all treatments. This generally provides effective protec-
tion of the cells against apoptosis [20 ] and can lead to a multi-drug
resistance [21 ].
4. Electro-Hyperthermia
Electro-hyperthermia is devoted to enhance the efficiency of con-
ventional hyperthermia by additional, mainly thermally induced, non-
thermal effects, and the aim of suppressing the existing disadvan-
tages of classical thermal treatments. Its advantage is that electri-
cally-coupled energy of certain frequencies are primarily absorbed in
the ECM, as it is not able to penetrate through the membrane (Fig.1.).
The temperature gradient from the ECM to the cell creates a
tremendous heat-flow (1500 nW/mm2) through the membrane. This
is well above the natural metabolic heat-flow of 20 nW/mm2. Moreo-
ver, the high temperature gradient (1 K/mm) forces membrane cur-
rents of approximately 150 pA/mm2, which is dominantly caused by
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Na+ influx. In addition, the thermal flux increases intracellular pres-
sure to 1.32 MPa. The membranes of a significant percent of malig-
nant cells are rigid [22 ], and cannot protect against this increased
pressure.
These processes lead to the cell membrane damage of the malignant
cells before the heat reaches the cell-nuclei, and could induce HSP
synthesis and adaptation to the new stress. However, membrane HSPs
are induced by the extreme heat at the membrane. These support
apoptotic signals and help eliminate the malignant cells in a natural
fashion.
The developed system is technically and medically certified by
the European Standards according to the Medical Device Directive.
5. Conclusions
Hyperthermia is one of the effective modalities in oncology. Its
improved version, electro-hyperthermia, is highly selective, gentle
and safe, providing all the positive effects of classical hyperthermia
with the additional advantages of:
1) reobtained apoptotic signal,
2) blocked angiogenesis,
3) blocked HSP synthesis within the cell, thus no heat tolerance
or other shock resistance can develop.
The successful operation of electro-hyperthermia systems is in
progress in various clinics and hospitals.
Fig.1. The RF current flows extracellularly
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